Loading clinical trials...
Loading clinical trials...
Clinical Efficacy of Personalized Exercise Program and an Inhibitor of Fatty Acid β-oxidation in Rehabilitation of Patients With Atrial Fibrillation After Primary Radiofrequency Ablation of Pulmonary Venous Orifices
Conditions
Interventions
Physical training program
Trimetazidine
Start Date
July 1, 2013
Primary Completion Date
December 1, 2016
Completion Date
April 1, 2017
Last Updated
June 9, 2021
NCT06557876
NCT07018596
NCT03323099
NCT05328882
NCT06058468
Lead Sponsor
National Research Center for Preventive Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions